Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 25

1.

Genetic testing of children for adult-onset conditions: opinions of the British adult population and implications for clinical practice.

Shkedi-Rafid S, Fenwick A, Dheensa S, Lucassen AM.

Eur J Hum Genet. 2015 Oct;23(10):1281-5. doi: 10.1038/ejhg.2014.221. Epub 2014 Nov 5.

2.

Genetic testing of children for predisposition to mood disorders: anticipating the clinical issues.

Erickson JA, Kuzmich L, Ormond KE, Gordon E, Christman MF, Cho MK, Levinson DF.

J Genet Couns. 2014 Aug;23(4):566-77. doi: 10.1007/s10897-014-9710-y. Epub 2014 Mar 22.

3.

Addressing the ethical challenges in genetic testing and sequencing of children.

Clayton EW, McCullough LB, Biesecker LG, Joffe S, Ross LF, Wolf SM; Clinical Sequencing Exploratory Research (CSER) Consortium Pediatrics Working Group.

Am J Bioeth. 2014;14(3):3-9. doi: 10.1080/15265161.2013.879945.

4.

Experience, knowledge, and opinions about childhood genetic testing in Batten disease.

Adams HR, Rose K, Augustine EF, Kwon JM, deBlieck EA, Marshall FJ, Vierhile A, Mink JW, Nance MA.

Mol Genet Metab. 2014 Feb;111(2):197-202. doi: 10.1016/j.ymgme.2013.10.017. Epub 2013 Nov 4.

5.

A review of quality of life after predictive testing for and earlier identification of neurodegenerative diseases.

Paulsen JS, Nance M, Kim JI, Carlozzi NE, Panegyres PK, Erwin C, Goh A, McCusker E, Williams JK.

Prog Neurobiol. 2013 Nov;110:2-28. doi: 10.1016/j.pneurobio.2013.08.003. Epub 2013 Sep 11. Review.

6.

Growing up in the genomic era: implications of whole-genome sequencing for children, families, and pediatric practice.

Wade CH, Tarini BA, Wilfond BS.

Annu Rev Genomics Hum Genet. 2013;14:535-55. doi: 10.1146/annurev-genom-091212-153425. Epub 2013 Jul 15. Review.

7.

Molecular genetics and genetic testing in myotonic dystrophy type 1.

Savić Pavićević D, Miladinović J, Brkušanin M, Šviković S, Djurica S, Brajušković G, Romac S.

Biomed Res Int. 2013;2013:391821. doi: 10.1155/2013/391821. Epub 2013 Mar 18. Review.

8.

Psychosocial aspects of predictive genetic testing for acute intermittent porphyria in norwegian minors.

Andersen J, Sandberg S, Raaheim M, Gjengedal E.

JIMD Rep. 2011;1:1-7. doi: 10.1007/8904_2011_8. Epub 2011 Jun 22.

9.

Perspectives of clinical genetics professionals toward genome sequencing and incidental findings: a survey study.

Lemke AA, Bick D, Dimmock D, Simpson P, Veith R.

Clin Genet. 2013 Sep;84(3):230-6. doi: 10.1111/cge.12060. Epub 2012 Dec 7.

10.

Knowledge and perceptions of familial and genetic risks for breast cancer risk in adolescent girls.

Bradbury AR, Patrick-Miller L, Egleston BL, Schwartz LA, Sands CB, Shorter R, Moore CW, Tuchman L, Rauch P, Malhotra S, Rowan B, Van Decker S, Schmidheiser H, Bealin L, Sicilia P, Daly MB.

Breast Cancer Res Treat. 2012 Dec;136(3):749-57. doi: 10.1007/s10549-012-2254-7. Epub 2012 Oct 14.

11.

Do Breast Cancer Patients Tested in the Oncology Care Setting Share BRCA Mutation Results with Family Members and Health Care Providers?

Vadaparampil ST, Malo T, de la Cruz C, Christie J.

J Cancer Epidemiol. 2012;2012:498062. doi: 10.1155/2012/498062. Epub 2012 Jul 15.

12.

Genetic Testing for Minors: Comparison between Italian and British Guidelines.

Tozzo P, Caenazzo L, Rodriguez D.

Genet Res Int. 2012;2012:786930. doi: 10.1155/2012/786930. Epub 2012 Mar 6.

13.

The role of disease characteristics in the ethical debate on personal genome testing.

Bunnik EM, Schermer MH, Janssens AC.

BMC Med Genomics. 2012 Jan 19;5:4. doi: 10.1186/1755-8794-5-4.

14.

When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response.

Bradbury AR, Patrick-Miller L, Egleston BL, Olopade OI, Daly MB, Moore CW, Sands CB, Schmidheiser H, Kondamudi PK, Feigon M, Ibe CN, Daugherty CK.

Cancer. 2012 Jul 1;118(13):3417-25. doi: 10.1002/cncr.26471. Epub 2012 Jan 9.

15.

Parents' attitudes toward pediatric genetic testing for common disease risk.

Tercyak KP, Hensley Alford S, Emmons KM, Lipkus IM, Wilfond BS, McBride CM.

Pediatrics. 2011 May;127(5):e1288-95. doi: 10.1542/peds.2010-0938. Epub 2011 Apr 18.

16.

The clinical utility of molecular diagnostic testing for primary immune deficiency disorders: a case based review.

Ameratunga R, Woon ST, Neas K, Love DR.

Allergy Asthma Clin Immunol. 2010 Jun 8;6(1):12. doi: 10.1186/1710-1492-6-12.

17.

Consensus and controversies in best practices for molecular genetic testing of spinocerebellar ataxias.

Sequeiros J, Seneca S, Martindale J.

Eur J Hum Genet. 2010 Nov;18(11):1188-95. doi: 10.1038/ejhg.2010.10. Epub 2010 Feb 24.

18.

Controversies in communication of genetic screening results for cancer: a report from the American Society of Preventive Oncology's Screening Special Interest Group (ASPO's 33rd Annual Meeting, March 8 to 10, 2009, Tampa, Florida).

Patrick-Miller L, Bradbury AR, Terry MB.

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):624-7. doi: 10.1158/1055-9965.EPI-19-2-ASPO01. Review. No abstract available.

19.

Attitudes toward genetic testing in childhood and reproductive decision-making for familial adenomatous polyposis.

Douma KF, Aaronson NK, Vasen HF, Verhoef S, Gundy CM, Bleiker EM.

Eur J Hum Genet. 2010 Feb;18(2):186-93. doi: 10.1038/ejhg.2009.151. Epub 2009 Oct 7.

20.

Ethicolegal aspects of genetics in surgical practice.

Lucassen A.

Ann R Coll Surg Engl. 2009 Sep;91(6):451-5. doi: 10.1308/003588409X464496. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk